Dr. Maarten G. Lansberg, MD

Dr. Lansberg practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lansberg's NPI, 1275690430, was assigned on January 3, 2007. Dr. Lansberg graduated from Utrecht University Faculty of Medicine in 1997. Dr. Lansberg holds California license A75890.

Dr. Lansberg's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lansberg's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lansberg to 1 more hospital and 1 medical group, each named with a free account. Dr. Lansberg's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lansberg practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Lansberg's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Lansberg is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Lansberg is licensed in California.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, lower back pain, mini-stroke (TIA), seizures, stroke and vertigo among the conditions Dr. Lansberg treats.

CMS data shows 215 Medicare services from Dr. Lansberg across 6 procedure codes in 2024, for 143 Medicare patients. Medicare paid $21,043 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Lansberg in 2024. The largest group is 75 to 84, with 57 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lansberg's median patient age at 63, with 54% women.

In 2024, Dr. Lansberg wrote 63 Medicare Part D claims for 19 patients. 100% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $965 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lansberg for performance year 2024, reported as part of a group. Dr. Lansberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lansberg as offering telehealth.

Dmand AI links 316 papers to Dr. Lansberg, published from 2006 to 2025. 2021 was the busiest year, with 36. The most frequent topics are Stroke, Brain Ischemia and Thrombectomy. Dr. Lansberg has published most often in Stroke. Dr. Lansberg's most frequent co-authors are Gregory W. Albers, MD, Michael Paul Marks, MD and Jeremy Josef Heit, MD, PhD.

Dmand AI links Dr. Lansberg to 7 clinical trials. Conditions studied include Stroke, Cerebrovascular Disorders and Cerebral Hemorrhage. Stanford University sponsors the most, 5.

CMS Open Payments shows 26 general payments to Dr. Lansberg from 5 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 97% of the total. Genentech, Inc. paid the most, $92,743. It also lists 7 research payments totaling $37,718 from 2018 to 2024.

Dmand AI lists 1 award for Dr. Lansberg, most recently CMS Stage 1 EHR in 2013.

Dr. Lansberg graduated from Utrecht University Faculty of Medicine in 1997.

Dr. Lansberg is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.